Design Therapeutics, Inc. (DSGN)
13.16
+0.04
(+0.30%)
USD |
NASDAQ |
Apr 20, 16:00
13.29
+0.13
(+0.99%)
After-Hours: 20:00
Design Therapeutics EPS Diluted (Quarterly) : -0.2724 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 1.150 |
| vTv Therapeutics, Inc. | -0.5752 |
| Tactile Systems Technology, Inc. | 0.4615 |
| Immuneering Corp. | -0.1793 |
| X4 Pharmaceuticals, Inc. | -0.2164 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.00M |
| Total Expenses (Quarterly) | 16.00M |
| Enterprise Value | 593.30M |
| Earnings Yield | -9.26% |
| Normalized Earnings Yield | -9.259 |